Currently, there is no clinical test to confirm Alzheimer’s disease in a living person. Microsoft co-founder Bill Gates wants to change that.
Gates announced he is directing more than $30 million to the Diagnostics Accelerator, a project dedicated to finding new diagnosis strategies. If the effort succeeds, senior living operators stand to benefit in several ways.
First, it would give residents, their families and operators a disease confirmation. That could greatly enhance and direct caregiving strategies and, perhaps, involvement in clinical trials. Moreover, it could help researchers unlock root causes and a perhaps a cure, according to experts.
Currently, clinicians must rely almost exclusively on efforts that merely suggest the disease’s presence. These include cognitive tests, spinal fluid analysis and PET brain imaging.
In a related blog post, Gates noted the goal is to help find a “real product for real patients.”
“Imagine a world where diagnosing Alzheimer’s disease is as simple as getting your blood tested during your annual physical,” he wrote.